Literature DB >> 30755741

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

David M Hyman1, Sarina A Piha-Paul2, Helen Won3, Jordi Rodon4, Cristina Saura4, Geoffrey I Shapiro5, Dejan Juric6, David I Quinn7, Victor Moreno8, Bernard Doger8, Ingrid A Mayer9, Valentina Boni10, Emiliano Calvo10, Sherene Loi11, Albert C Lockhart12, Joseph P Erinjeri3, Maurizio Scaltriti3, Gary A Ulaner3, Juber Patel3, Jiabin Tang3, Hannah Beer3, S Duygu Selcuklu3, Aphrothiti J Hanrahan3, Nancy Bouvier3, Myra Melcer3, Rajmohan Murali3, Alison M Schram3, Lillian M Smyth3, Komal Jhaveri3, Bob T Li3, Alexander Drilon3, James J Harding3, Gopa Iyer3, Barry S Taylor3, Michael F Berger3, Richard E Cutler13, Feng Xu13, Anna Butturini13, Lisa D Eli13, Grace Mann13, Cynthia Farrell13, Alshad S Lalani13, Richard P Bryce13, Carlos L Arteaga9, Funda Meric-Bernstam2, José Baselga3, David B Solit3.   

Abstract

The 'Competing interests' statement of this Article has been updated; please see the accompanying Amendment. The original Article has not been corrected online.

Entities:  

Year:  2019        PMID： 30755741     DOI： 10.1038/s41586-019-0974-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


  4 in total

1.  Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine.

Authors:  Sebastian Mondaca; Pedram Razavi; Chongrui Xu; Michael Offin; Mackenzie Myers; Maurizio Scaltriti; Jaclyn F Hechtman; Mikaela Bradley; Eileen M O'Reilly; Michael F Berger; David B Solit; Bob T Li; Ghassan K Abou-Alfa
Journal:  JCO Precis Oncol       Date:  2019-10-17

2.  Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy.

Authors:  Giovanni Randon; Giulia Maddalena; Marco Maria Germani; Chiara Carlotta Pircher; Paolo Manca; Francesca Bergamo; Mirella Giordano; Caterina Sposetti; Aldo Montagna; Guglielmo Vetere; Luca Zambelli; Cosimo Rasola; Alessandra Boccaccino; Filippo Pagani; Margherita Ambrosini; Marco Massafra; Gabriella Fontanini; Massimo Milione; Matteo Fassan; Chiara Cremolini; Sara Lonardi; Filippo Pietrantonio
Journal:  JCO Precis Oncol       Date:  2022-04

Review 3.  Efficacy of targeted therapy in patients with HER2-positive non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Hong-Xia Wu; Kai-Quan Zhuo; Ke Wang
Journal:  Br J Clin Pharmacol       Date:  2021-12-21       Impact factor: 3.716

4.  Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer.

Authors:  Brittany Rupp; Sarah Owen; Harrison Ball; Kaylee Judith Smith; Valerie Gunchick; Evan T Keller; Vaibhav Sahai; Sunitha Nagrath
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.